GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Catalyst Pharmaceutical Partners, Inc. (CPRX) [hlAlert]

Catalyst Pharmaceutical Partners, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of prescription drugs for the treatment of addiction and obsessive-compulsive disorders. Its product candidate CPP-109, which is the version
of the chemical compound gamma-vinyl-GABA, referred to as vigabatrin. As of December 31, 2008, the Company was conducting two clinical trials of CPP-109, one evaluating its use in the treatment of cocaine addiction, and a second evaluating its use in the treatment of methamphetamine addiction. CPP-109 has the potential to treat other addictions, including addictions to nicotine, prescription pain, medications, alcohol, and marijuana, as well as obsessive-compulsive disorders, such as obesity and compulsive gambling.
.
( Total: 7 Current Stock Recommendations )
Catalyst Pharmaceutical Partners, Inc.   (7)
Sell 29% Hold Buy 57%
Related companies
DARA BIOSCIENCES   (2)
Buy 100%
CELSION CORP   (6)
Buy 100%
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Filter by Gains:   
  
Rating:
Buy CPRX
up 14.73 %

Rating:
Buy CPRX
up 632.00 %

Rating:
Buy CPRX
up 24.48 %

Rating:
Buy CPRX
up 632.00 %

Rating:
Buy CPRX
up 632.00 %

Rating:
Hold CPRX

Rating:
Sell CPRX
down 53.88 %

Rating:
Sell CPRX
down 77.04 %

Rating:
Buy CPRX
down 53.88 %

Rating:
Buy CPRX
up 29.32 %
Catalyst Pharmaceutical Partners, Inc. (CPRX) rated Buy
Wednesday,  Nov 28, 2007  9:25 AM ET

Your Recent Stocks
SymbolLastChange
CPRX 0.58 down  -84.23 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy